8.98
Adapthealth Corp stock is traded at $8.98, with a volume of 1.27M.
It is up +0.00% in the last 24 hours and up +7.29% over the past month.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
See More
Previous Close:
$8.98
Open:
$8.92
24h Volume:
1.27M
Relative Volume:
0.77
Market Cap:
$1.21B
Revenue:
$3.26B
Net Income/Loss:
$-214.34M
P/E Ratio:
-5.4424
EPS:
-1.65
Net Cash Flow:
$229.32M
1W Performance:
+2.28%
1M Performance:
+7.29%
6M Performance:
-10.47%
1Y Performance:
-7.33%
Adapthealth Corp Stock (AHCO) Company Profile
Name
Adapthealth Corp
Sector
Industry
Phone
610-424-4515
Address
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AHCO
Adapthealth Corp
|
8.98 | 1.18B | 3.26B | -214.34M | 229.32M | -1.65 |
![]()
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-08-24 | Downgrade | Jefferies | Buy → Hold |
Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
May-10-23 | Downgrade | Deutsche Bank | Buy → Hold |
May-10-23 | Downgrade | Stifel | Buy → Hold |
May-09-23 | Downgrade | BofA Securities | Buy → Neutral |
Sep-27-21 | Initiated | SVB Leerink | Outperform |
Jul-14-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Apr-13-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mar-18-21 | Initiated | Truist | Buy |
Jan-26-21 | Initiated | BofA Securities | Buy |
Dec-10-20 | Initiated | UBS | Buy |
Aug-10-20 | Initiated | Canaccord Genuity | Buy |
Jul-01-20 | Resumed | SVB Leerink | Outperform |
Jun-09-20 | Initiated | RBC Capital Mkts | Outperform |
Jan-31-20 | Initiated | Stifel | Buy |
Jan-07-20 | Initiated | Jefferies | Buy |
Dec-11-19 | Initiated | SVB Leerink | Outperform |
Dec-10-19 | Initiated | Deutsche Bank | Buy |
View All
Adapthealth Corp Stock (AHCO) Latest News
Where are the Opportunities in (AHCO) - news.stocktradersdaily.com
Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks - The Globe and Mail
Deadline Approaching for Receiving Share of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (AHCO) RecoveryContact Levi & Korsinsky, LLP for Further Details - ACCESS Newswire
AdaptHealth to Join RBCCM Global Healthcare Conference with Fireside Chat - MSN
Adapthealth at RBC Conference: Strategic Moves and Challenges - Investing.com Australia
Adapthealth revises 2025 revenue guidance to $3.18B-$3.32B amid asset sales and operational improvements - MSN
(AHCO) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
AdaptHealth Reports First Quarter 2025 Financial Results, Updates Guidance - MSN
AdaptHealth’s SWOT analysis: stock faces challenges amid diabetes sector recovery - Investing.com India
AdaptHealth Corp. Q1 FY2025: Strong Performance Amid Sales DeclineNews and Statistics - IndexBox
AHCO Q1 Earnings Call: Guidance Trimmed as Diabetes and Sleep Segments Face Mixed Recovery - Yahoo Finance
We Like The Quality Of AdaptHealth's (NASDAQ:AHCO) Earnings - Yahoo Finance
We Think AdaptHealth's (NASDAQ:AHCO) Solid Earnings Are Understated - simplywall.st
AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates - MSN
AdaptHealth Corp. to Participate in Upcoming Investor Conferences - The Joplin Globe
AdaptHealth (AHCO) Price Target Reduced by Truist, Buy Rating Ma - GuruFocus
AdaptHealth (AHCO) Rating Maintained, Price Target Lowered by Tr - GuruFocus
When the Price of (AHCO) Talks, People Listen - news.stocktradersdaily.com
AdaptHealth’s diabetes biz continues to lag - HME News
AdaptHealth Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st
Pacer Advisors, Inc. Acquires Significant Stake in AdaptHealth Corp - GuruFocus
AdaptHealth Strategizes To Tackle Tariffs With Confidence - Finimize
AdaptHealth (AHCO): RBC Capital Lowers Price Target to $13 | AHC - GuruFocus
AdaptHealth (AHCO): RBC Capital Lowers Price Target to $13 | AHCO Stock News - GuruFocus
AdaptHealth Sees Minimal Tariff Impact, Diabetes Segment 'Turning a Corner,' RBC Says - marketscreener.com
AdaptHealth First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
AdaptHealth Q1 Net Loss Widens as Revenue Drops - marketscreener.com
RBC Lowers Price Target on AdaptHealth to $13 From $14, Keeps Outperform Rating - marketscreener.com
Q1 Earnings Highs And Lows: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks - FinancialContent
AdaptHealth Corp (AHCO) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
AdaptHealth Corp (AHCO) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
AdaptHealth Corp. (NASDAQ:AHCO) Q1 2025 Earnings Call Transcript - Insider Monkey
AdaptHealth Reports Q1 2025 Financial Results - TipRanks
Adapthealth earnings missed by $0.15, revenue topped estimates - Investing.com
AdaptHealth (AHCO) Exceeds Q1 2025 Revenue Expectations - GuruFocus
AdaptHealth’s Mixed Earnings Call Highlights Progress and Challenges - TipRanks
AdaptHealth Corp (AHCO) Q1 2025 Earnings: Revenue Beats Estimates at $777.9M, Reports Net Loss of $7.2M - GuruFocus
AdaptHealth (AHCO) Surpasses Revenue Forecast in Q1 | AHCO Stock News - GuruFocus
AdaptHealth Exceeds Revenue Expectations Amidst Sales DeclineNews and Statistics - IndexBox
AdaptHealth (AHCO) Exceeds Q1 Revenue Expectations | AHCO Stock News - GuruFocus
AdaptHealth Corp. Announces First Quarter 2025 Results | AHCO St - GuruFocus
Commit To Buy AdaptHealth At $7.50, Earn 10% Using Options - Nasdaq
AdaptHealth ‘stays the course’ for Q1 - HME News
Earnings call transcript: Adapthealth Q1 2025 misses EPS forecast, stock rises - Investing.com India
AdaptHealth Q1 2025 slides: revenue and profitability decline amid segment challenges - Investing.com
AdaptHealth (AHCO) Surpasses Q1 Revenue Expectations | AHCO Stoc - GuruFocus
Adapthealth Corp Stock (AHCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adapthealth Corp Stock (AHCO) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Clemens Jason A | Chief Financial Officer |
Dec 10 '24 |
Sale |
9.35 |
35,000 |
327,250 |
420,719 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):